Randomized study of the safety and efficacy of fish oil (omega-3 fatty acid) supplementation with dietary and exercise counseling for the treatment of antiretroviral therapy-associated hypertriglyceridemia.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Clinical Infectious Diseases

• Publication date

  2005-11-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1086/497273PMID 16231263
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial.

  2004cited by this paper
• Combination antiretroviral therapy and the risk of myocardial infarction.

  2003cited by this paper
• Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy: recommendations of the HIV Medical Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group.

  2003cited by this paper
• Combination antiretroviral therapy and the risk of myocardial infarction

  2003cited by this paper
• Increased use of lipid-lowering therapy in patients receiving human immunodeficiency virus protease inhibitors.

  2003cited by this paper
• Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease.

  2003cited by this paper
• Omega-3 Fatty Acids and Cardiovascular Disease: New Recommendations From the American Heart Association

  2003cited by this paper
• Simvastatin-nelfinavir interaction implicated in rhabdomyolysis and death.

  2002cited by this paper
• Early Protection Against Sudden Death by n-3 Polyunsaturated Fatty Acids After Myocardial Infarction: Time-Course Analysis of the Results of the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico (GISSI)-Prevenzione

  2002cited by this paper
• Effect of dietary intervention on highly active antiretroviral therapy-related dyslipemia.

  2002cited by this paper
• Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease.

  2002cited by this paper
• Protease inhibitors and cardiovascular outcomes in patients with HIV-1.

  2002cited by this paper
• RAPID COMMUNICATIONS: MANAGEMENT OF METABOLIC COMPLICATIONS ASSOCIATED WITH ANTIRETROVIRAL THERAPY FOR HIV-1 INFECTION: RECOMMENDATIONS OF AN INTERNATIONAL AIDS SOCIETY-USA PANEL

  2002cited by this paper
• N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials.

  2002cited by this paper
• Pharmacokinetic interactions between protease inhibitors and statins in HIV seronegative volunteers: ACTG Study A5047

  2002cited by this paper
• Efficacy and safety of fenofibrate for the treatment of hypertriglyceridemia associated with antiretroviral therapy.

  2002cited by this paper
• Blood levels of long-chain n-3 fatty acids and the risk of sudden death.

  2002cited by this paper
• Early Protection Against Sudden Death by n-3 Polyunsaturated Fatty Acids After Myocardial Infarction Time-Course Analysis of the Results of the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico (GISSI)-Prevenzione

  2002cited by this paper
• AHA Dietary Guidelines: revision 2000: A statement for healthcare professionals from the Nutrition Committee of the American Heart Association.

  2000cited by this paper
• Effects of protease inhibitors on hyperglycemia, hyperlipidemia, and lipodystrophy: a 5-year cohort study.

  2000cited by this paper
• Hyperlipidemia and insulin resistance are induced by protease inhibitors independent of changes in body composition in patients with HIV infection.

  2000cited by this paper
• Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG Adherence Instruments

  2000cited by this paper
• Safety and Efficacy of HMG‐CoA Reductase Inhibitors for Treatment of Hyperlipidemia in Patients with HIV Infection

  2000cited by this paper
• Hyperlipidemia and Insulin Resistance Are Induced by Protease Inhibitors Independent of Changes in Body Composition in Patients With HIV Infection

  2000cited by this paper
• Incidence of myocardial infarctions in HIV-infected patients between 1983 and 1998: the Frankfurt HIV-cohort study.

  2000cited by this paper
• Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors. The Swiss HIV Cohort Study.

  1999cited by this paper
• Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico.

  1999cited by this paper
• Fish consumption and risk of sudden cardiac death.

  1998cited by this paper
• Fish consumption, fish oil, lipids, and coronary heart disease.

  1997cited by this paper
• n-3 fatty acids and serum lipoproteins: human studies.

  1997cited by this paper
• n-3 fatty acids and serum lipoproteins: animal studies.

  1997cited by this paper
• Fish consumption, fish oil, lipids, and coronary heart disease.

  1996cited by this paper
• Validity and reliability of self-reported physical activity status: the Lipid Research Clinics questionnaire.

  1993cited by this paper
• Fish oil supplementation results in decreased hypertriglyceridemia in patients with psoriasis undergoing etretinate or acitretin therapy.

  1988cited by this paper
• Reduction of postprandial triglyceridemia in humans by dietary n-3 fatty acids.

  1988cited by this paper
• Effect of Dietary Fish Oil on Hyperlipidaemia due to Isotretinoin and Etretinate

  1987cited by this paper
• Reduction of plasma lipids, lipoproteins, and apoproteins by dietary fish oils in patients with hypertriglyceridemia.

  1986cited by this paper
• Reduction of Plasma Lipids, Lipoproteins, and Apoproteins by Dietary Fish Oils in Patients with Hypertriglyceridemia

  1985cited by this paper

• Effects of Docosahexanoic Acid on Gut Microbiota and Fecal Metabolites in HIV-Infected Patients With Neurocognitive Impairment: A 6-Month Randomized, Double-Blind, Placebo-Controlled Trial

  2022cites this paper
• Therapeutic Lipidology

  2021cites this paper
• HIV and Dyslipidemia

  2020cites this paper
• Omega-3 fatty acids ameliorate cognitive dysfunction in schizophrenia patients with metabolic syndrome.

  2020cites this paper
• Relationships between Atherosclerosis and Plasma Antioxidant Micronutrients or Red Blood Cell Polyunsaturated Fatty Acids in People Living with HIV

  2019cites this paper
• Diagnosis and Management of Dyslipidemia

  2019cites this paper
• Current pharmacotherapy for the treatment of dyslipidemia associated with HIV infection

  2019cites this paper
• Nutritional Issues and Positive Living in Human Immunodeficiency Virus/AIDS.

  2018cites this paper
• docosahexanoic acid supplementation on in fl ammatory and subcutaneous adipose tissue gene expression in HIV-infected patients on combination antiretroviral therapy ( cART ) . A sub-study of a randomized , double-blind , placebo-controlled study

  2018cites this paper
• Effect of fish oil omega-3 fatty acids on reduction of depressive symptoms among HIV-seropositive pregnant women: a randomized, double-blind controlled trial

  2018cites this paper
• Effects of docosahexanoic acid supplementation on inflammatory and subcutaneous adipose tissue gene expression in HIV‐infected patients on combination antiretroviral therapy (cART). A sub‐study of a randomized, double‐blind, placebo‐controlled study

  2018cites this paper
• Valutazione diagnostica e trattamento della dislipidemia nel paziente in terapia HAART

  2017cites this paper
• Effectiveness of n-3 fatty acids in the treatment of hypertriglyceridemia in HIV/AIDS patients: a meta-analysis.

  2017influential citation
• Effects of docosahexanoic acid on metabolic and fat parameters in HIV-infected patients on cART: A randomized, double-blind, placebo-controlled study.

  2017cites this paper
• Soy Protein Isolate Suppresses Lipodystrophy-induced Hepatic Lipid Accumulation in Model Mice.

  2017cites this paper
• Chapter 37 – Lipodystrophy Syndromes

  2016cites this paper
• Drug therapies for HIV-related metabolic disorders

  2016cites this paper
• An Evaluation of the Antibacterial, Anti-Giardial, Anticancer and Toxicity Properties of Selected Nut Extracts

  2016cites this paper
• Effect of Omega-3 Fatty Acids on Depressive Symptoms in HIV-Positive Individuals

  2016cites this paper
• Lipid Management in Human Immunodeficiency Virus.

  2016cites this paper
• Clinical management of dyslipidaemia associated with combination antiretroviral therapy in HIV-infected patients.

  2016cites this paper
• Alcoholic Extract of Lotus Leaves Improves Lipid Profile in Rats with HIV Protease Inhibitor-induced Dyslipidaemia.

  2015cites this paper
• Effect of fish oil Omega-3 fatty acids on reduction of depressive symptoms among HIV-seropositive pregnant women

  2015cites this paper
• The Use of Medium Chain Triglycerides in the Management of Severe Refractory Hypertriglyceridemia: A Case Report

  2015cites this paper
• Exercise and Management of Body Weight in Older People Living with HIV

  2015cites this paper
• Nutrition Therapy for Adults with HIV on ART

  2015cites this paper
• Dietary Intervention for Dyslipidemia in Human Immunodeficiency Virus Infection

  2015cites this paper
• Management of lipid disorders in patients living with HIV

  2015cites this paper
• Effects of Omega-3 Fatty Acids on Body Composition and Health in HIV/AIDS During HAART Therapy

  2015cites this paper
• Leptin in congenital and HIV-associated lipodystrophy.

  2015cites this paper
• Dyslipidemia in HIV-Infected Patients

  2015cites this paper
• Cardiovascular Diseases in HIV and Aging

  2015cites this paper
• Nutrition and Food in AIDS Patients

  2015cites this paper
• Lipid management in human immunodeficiency virus.

  2015cites this paper
• Prevalence, underlying mechanisms and role of nutrition in the management of the HIV-associated lipodystrophy syndrome

  2015cites this paper
• Treatment of Dyslipidemia in HIV

  2015cites this paper
• Prevalence of Metabolic Syndrome Among Antiretroviral-Naive and Antiretroviral-Experienced HIV-1 Infected Thai Adults

  2014cites this paper
• Supplemental substances derived from foods as adjunctive therapeutic agents for treatment of neurodegenerative diseases and disorders.

  2014cites this paper
• Remedies Fish oil and its effects on inflammation in HIV-infected persons: A preliminary review

  2014cites this paper
• Effects of fish oil on lipid profile and other metabolic outcomes in HIV-infected patients on antiretroviral therapy: a randomized placebo-controlled trial

  2014cites this paper
• Nutritional Treatment for Traumatic Brain Injury

  2014cites this paper
• Triglyceride-lowering agents.

  2014cites this paper
• Short communication: effects of omega-3 fatty acids on triglycerides and high-density lipoprotein subprofiles in HIV-infected persons with hypertriglyceridemia.

  2014cites this paper
• Management of dyslipidemia in patients with human immunodeficiency virus.

  2014cites this paper
• Omega-3 Fatty Acids as a Putative Treatment for Traumatic Brain Injury

  2013cites this paper
• Nutritional interventions for reducing morbidity and mortality in people with HIV.

  2013cites this paper
• Omega‐3 fatty acid therapy reduces triglycerides and interleukin‐6 in hypertriglyeridemic HIV patients

  2013cites this paper
• Comparative Effectiveness of Fish Oil Versus Fenofibrate, Gemfibrozil, and Atorvastatin on Lowering Triglyceride Levels Among HIV-Infected Patients in Routine Clinical Care

  2013cites this paper
• Exploratory Study: Evaluating the Effects of Fish Oil and Controlled Diet to Reduce Triglyceride Levels in HIV

  2013cites this paper
• The Nutritional Management of Complications Associated with HIV and Antiretroviral Therapy

  2013cites this paper
• Chapter 48 – Manifestations, Mechanisms, and Treatment of HIV-Associated Cardiovascular Disease

  2013cites this paper
• Utilização so ácido graxo ômega-3 na hipertrigliceridemia de indivíduos com HIV/Aids: relação com níveis de citocinas

  2013cites this paper
• Management of the metabolic effects of HIV and HIV drugs

  2012cites this paper
• Nutrition and the HIV-associated lipodystrophy syndrome

  2012cites this paper
• Impact of Switch to Fosamprenavir and Addition of Lovaza ® for Treatment of Hypertriglyceridemia in HIV-Infected Subjects on Antiretroviral Therapy

  2012cites this paper
• The effect of a 12-week course of omega-3 polyunsaturated fatty acids on lipid parameters in hypertriglyceridemic adult HIV-infected patients undergoing HAART: a randomized, placebo-controlled pilot trial.

  2012cites this paper
• [Nutritional therapy in metabolic changes in individuals with HIV/AIDS].

  2012cites this paper
• The Effects of Dietary Intervention on HIV Dyslipidaemia: A Systematic Review and Meta-Analysis

  2012cites this paper
• Omega-3 Fatty Acids Do Not Improve Endothelial Function In Virologically Suppressed HIV-Infected Men: A Randomized Placebo-Controlled Trial

  2012cites this paper
• Clinical Management Considerations for Dyslipidemia in HIV–Infected Individuals

  2012cites this paper
• Management of dyslipidemia in HIV-infected patients.

  2011cites this paper
• Hypertriglyceridemia, Metabolic Syndrome, and Cardiovascular Disease in HIV-Infected Patients: Effects of Antiretroviral Therapy and Adipose Tissue Distribution

  2011cites this paper
• Nutritional and metabolic correlates of cardiovascular and bone disease in HIV-infected patients.

  2011cites this paper
• Policosanol for managing human immunodeficiency virus-related dyslipidemia in a medically underserved population: a randomized, controlled clinical trial.

  2011cites this paper
• Dyslipidemia in HIV-infected individuals Authors

  2011influential citation
• HIV and HAART-Associated Dyslipidemia

  2011cites this paper
• Omega-3 Fatty Acids and Hypertriglyceridemia in HIV-Infected Subjects on Antiretroviral Therapy: Systematic Review and Meta-analysis

  2011cites this paper
• Management of dyslipidemia in HIV-infected patients

  2011cites this paper
• HIV with Dyslipidemia

  2011cites this paper
• Treatment of dyslipidemia in HIV-infected patients

  2010cites this paper
• Dyslipidemia in HIV-infected individuals.

  2010influential citation
• Fenofibrate in the treatment of dyslipidemia associated with HIV infection

  2010cites this paper
• Dislipidemia y virus de inmunodeficiencia adquirida/sida

  2010cites this paper
• HIV Infection and Diabetes

  2010cites this paper
• Dyslipidemia and its Treatment in HIV Infection.

  2010cites this paper
• Management of metabolic complications and cardiovascular risk in HIV-infected patients.

  2010cites this paper
• Pharmacological interventions for treating dyslipidemia in patients with HIV infection

  2010cites this paper
• Macronutrient supplementation and food prices in HIV treatment.

  2010cites this paper
• Position of the American Dietetic Association: Nutrition Intervention and Human Immunodeficiency Virus Infection.

  2010cites this paper
• Management of hypertriglyceridaemia caused by combination antiretroviral therapy in HIV-infected patients: role of omega-3 polyunsaturated fatty acids at different dosages, compared with fibrates

  2010cites this paper
• Severe Weight Gain, Lipodystrophy, Dyslipidemia, and Obstructive Sleep Apnea in an HIV-Infected Patient Following Highly Active Antiretroviral Therapy

  2010cites this paper
• Higher dietary intake of long-chain omega-3 polyunsaturated fatty acids is inversely associated with depressive symptoms in women.

  2009cites this paper
• Lipid management in patients who have HIV and are receiving HIV therapy.

  2009cites this paper
• Evaluación del riesgo cardiovascular e intervención en los pacientes con VIH

  2009cites this paper
• Fish Oil and Fenofibrate for the Treatment of Hypertriglyceridemia in HIV-Infected Subjects on Antiretroviral Therapy:

  2009cites this paper
• [Dietary intake and dyslipidemia arising from combination antiretroviral therapy for HIV infection: a systematic review].

  2009cites this paper
• [Cardiovascular risk assessment and intervention in HIV-infected patients].

  2009cites this paper
• Undernutrition in Patients with Infection HIV/AIDS

  2009cites this paper
• New Options in the Treatment of Lipid Disorders in HIV-Infected Patients

  2009cites this paper
• CHAPTER 43 – Special Patient Populations: HIV Patients

  2009cites this paper
• Effect of fish oil (n-3 polyunsaturated fatty acids) on plasma lipids, lipoproteins and inflammatory markers in HIV-infected patients treated with antiretroviral therapy: A randomized, double-blind, placebo-controlled study

  2009influential citation
• Long-chain omega-3 polyunsaturated fatty acids are inversely associated with depressive symptoms in women

  2009cites this paper
• Consumo alimentar e dislipidemia decorrente da terapia antirretroviral combinada para infecção pelo HIV: uma revisão sistemática

  2009cites this paper
• Effect of a dietary intervention and n-3 fatty acid supplementation on measures of serum lipid and insulin sensitivity in persons with HIV.

  2009cites this paper
• Severe weight gain, lipodystrophy, dyslipidemia, and obstructive sleep apnea in a human immunodeficiency virus-infected patient following highly active antiretroviral therapy.

  2008cites this paper
• The Relationship Between HIV Infection and Cardiovascular Disease

  2008cites this paper
• OMEGA-3 FATTY ACID SUPPLEMENTATION AND SLEEP

  2008cites this paper
• Use of Diet, Nutritional Supplements and Exercise in HIV-Infected Patients Receiving Combination Antiretroviral Therapies: A Systematic Review

  2008cites this paper
• Fish oil in the treatment of dyslipidemia

  2008cites this paper
• Fish Oil and Fenofibrate for the Treatment of Hypertriglyceridemia in HIV-Infected Subjects on Antiretroviral Therapy: Results of ACTG A5186

  2008cites this paper